| $337M | ||
| $259M | ||
| $100M | ||
| $79M | ||
| $60M | ||
| $58M |
Buys | $0 | 0 | 0 |
Sells | $3,531 | 2 | 100 |
| Chiang Pichi Luo | SVP, Corporate Controller | 0 | $0 | 1 | $1,130 | $-1,130 |
| Schiller Mark C. | Chief Operating Officer | 0 | $0 | 1 | $2,401 | $-2,401 |
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical trials for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b clinical trials in systemic lupus erythematosus and lupus nephritis. Its preclinical products include KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of KZR-261; and KZR-TBD for the treatment of oncology and immunology. The company was incorporated in 2015 and is based in South San Francisco, California.
Over the last 12 months, insiders at Kezar Life Sciences, Inc. have bought $0 and sold $3,531 worth of Kezar Life Sciences, Inc. stock.
On average, over the past 5 years, insiders at Kezar Life Sciences, Inc. have bought $295,400 and sold $980,348 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 20,000 shares for transaction amount of $295,400 was made by BERGER FRANKLIN M () on 2022‑03‑18.
| 2025-07-02 | Sale | Schiller Mark C. | Chief Operating Officer | 561 0.0073% | $4.28 | $2,401 | -0.89% | |
| 2025-07-02 | Sale | Chiang Pichi Luo | SVP, Corporate Controller | 264 0.0034% | $4.28 | $1,130 | -0.89% | |
| 2024-07-02 | Sale | Schiller Mark C. | Chief Legal Officer | 6,688 0.0084% | $0.58 | $3,879 | -88.48% | |
| 2023-02-06 | Sale | Morningside Venture Investments Ltd | 10 percent owner | 40,000 0.0558% | $6.88 | $275,320 | -69.99% | |
| 2023-02-03 | Sale | Morningside Venture Investments Ltd | 10 percent owner | 25,000 0.0348% | $7.15 | $178,650 | -70.14% | |
| 2023-02-02 | Sale | Morningside Venture Investments Ltd | 10 percent owner | 50,000 0.0681% | $7.19 | $359,500 | -70.86% | |
| 2023-02-01 | Sale | Morningside Venture Investments Ltd | 10 percent owner | 40,000 0.0558% | $6.95 | $278,000 | -68.99% | |
| 2023-01-31 | Sale | Morningside Venture Investments Ltd | 10 percent owner | 30,000 0.041% | $7.08 | $212,400 | -70.01% | |
| 2023-01-30 | Sale | Morningside Venture Investments Ltd | 10 percent owner | 30,000 0.041% | $6.91 | $207,300 | -68.71% | |
| 2023-01-25 | Sale | Morningside Venture Investments Ltd | director | 50,000 0.0697% | $6.85 | $342,500 | -67.35% | |
| 2023-01-24 | Sale | Morningside Venture Investments Ltd | director | 80,000 0.1103% | $6.98 | $558,400 | -68.05% | |
| 2023-01-23 | Sale | Morningside Venture Investments Ltd | director | 80,000 0.1109% | $6.81 | $544,800 | -66.76% | |
| 2023-01-17 | Sale | Morningside Venture Investments Ltd | director | 6,114 0.0088% | $6.79 | $41,514 | -64.18% | |
| 2023-01-13 | Sale | Morningside Venture Investments Ltd | director | 1,971 0.0029% | $7.15 | $14,093 | -65.50% | |
| 2023-01-12 | Sale | Morningside Venture Investments Ltd | director | 5,000 0.0068% | $6.77 | $33,850 | -65.80% | |
| 2023-01-06 | Sale | Morningside Venture Investments Ltd | director | 3,000 0.0042% | $6.89 | $20,670 | -65.20% | |
| 2023-01-05 | Sale | Morningside Venture Investments Ltd | director | 12,162 0.017% | $6.97 | $84,769 | -65.51% | |
| 2023-01-04 | Sale | Morningside Venture Investments Ltd | director | 30,000 0.0414% | $7.17 | $215,100 | -66.90% | |
| 2023-01-03 | Sale | Morningside Venture Investments Ltd | director | 500 0.0007% | $7.10 | $3,550 | -65.66% | |
| 2022-12-29 | Sale | Morningside Venture Investments Ltd | director | 25,000 0.0375% | $7.10 | $177,500 | -66.15% |
| Schiller Mark C. | Chief Operating Officer | 2739 0.0375% | $11,147.73 | 0 | 2 | |
| Chiang Pichi Luo | SVP, Corporate Controller | 2711 0.0371% | $11,033.77 | 0 | 1 | |
| Equal Talent Investments Ltd | 10 percent owner | 6254545 85.6107% | $25.46M | 1 | 0 | +13.64% |
| Morningside Venture Investments Ltd | 10 percent owner | 5447993 74.5708% | $22.17M | 2 | 19 | +69.08% |
| Cormorant Asset Management, LP | 10 percent owner | 1572909 21.5296% | $6.4M | 1 | 0 | |
| BERGER FRANKLIN M | 890691 12.1916% | $3.63M | 4 | 0 | +10.22% | |
| BAY CITY CAPITAL LLC | 10 percent owner | 622229 8.5169% | $2.53M | 1 | 0 | |
| Kirk Christopher J. | President and CSO | 342609 4.6895% | $1.39M | 3 | 0 | +69.08% |
| Kauffman Michael | director | 63690 0.8718% | $259,218.30 | 0 | 1 | |
| Fowler John Franklin | CEO | 38461 0.5264% | $156,536.27 | 4 | 0 | +55.28% |
| Belsky Marc | CFO | 15384 0.2106% | $62,612.88 | 6 | 0 | +71.3% |
| Economides Vassiliki | SVP, Strategy & External Aff. | 7570 0.1036% | $30,809.90 | 5 | 0 | +69.08% |
$17,268,389 | 57 | -18.16% | $30.21M | |
$53,490,060 | 55 | 19.35% | $30.06M | |
$6,204,522 | 45 | 1.91% | $25.39M | |
$22,323,743 | 39 | 23.92% | $33.16M | |
$23,895,365 | 34 | -37.28% | $33.15M | |
$1,995,470 | 22 | 14.01% | $23.26M | |
$2,553,853 | 17 | 16.69% | $33.65M | |
$20,234,041 | 17 | 2.09% | $33.52M | |
$36,557,692 | 17 | 3.38% | $31.99M | |
$139,007,129 | 16 | 47.16% | $30.57M | |
$39,336,371 | 14 | -17.87% | $22.8M | |
Kezar Life Sciences, Inc. (KZR) | $19,300,035 | 11 | 45.88% | $29.73M |
$189,648 | 9 | -52.20% | $21.37M | |
$1,472,879 | 6 | -13.59% | $27.93M | |
$149,996 | 5 | 16.26% | $29.3M | |
$147,504 | 5 | -36.70% | $21.44M | |
$157,740 | 3 | 153.95% | $31.04M | |
$100,266 | 2 | 3.17% | $29.49M | |
$30,190 | 1 | -42.39% | $25.11M |
| Increased Positions | 10 | +16.67% | 463,794 | +11.03% |
| Decreased Positions | 22 | -36.67% | 362,619 | -8.63% |
| New Positions | 4 | New | 86,954 | New |
| Sold Out Positions | 7 | Sold Out | 188,168 | Sold Out |
| Total Postitions | 48 | -20% | 4M | +2.41% |
| Tang Capital Management Llc | $2,916.00 | 10.29% | 720,000 | 0 | 0% | 2025-03-31 |
| Suvretta Capital Management, Llc | $2,903.00 | 10.24% | 716,759 | 0 | 0% | 2025-03-31 |
| Avidity Partners Management Lp | $2,036.00 | 7.18% | 502,600 | 0 | 0% | 2025-03-31 |
| Bml Capital Management, Llc | $1,653.00 | 5.83% | 408,138 | +359,470 | +738.62% | 2025-03-31 |
| Vanguard Group Inc | $1,119.00 | 3.95% | 276,228 | +2,117 | +0.77% | 2025-03-31 |
| Orbimed Advisors Llc | $780.00 | 2.75% | 192,700 | 0 | 0% | 2025-03-31 |
| Adar1 Capital Management, Llc | $597.00 | 2.11% | 147,404 | 0 | 0% | 2025-03-31 |
| Acadian Asset Management Llc | $541.00 | 1.91% | 133,525 | -12,141 | -8.34% | 2025-03-31 |
| Peapod Lane Capital Llc | $466.00 | 1.65% | 115,123 | -9,304 | -7.48% | 2025-06-30 |
| Sphera Funds Management Ltd. | $439.00 | 1.55% | 108,473 | 0 | 0% | 2025-03-31 |